Efficacy and safety of tacrolimus ointment in pediatric patients with moderate to severe atopic dermatitis

Journal of the Medical Association of Thailand

Volumn 89, Issue 11, 2006, Pages 1915-1922

  Singalavanija, Srisuphaluk ^a   Noppakun, Noppadon ^b   Limpongsanuruk, Wanida ^a   Wisuthsarewong, Wanee ^c   Aunhachoke, Kobkul ^d   Chunharas, Amornsri ^e   Wananukul, Siriwan ^b   Akaraphanth, Rutsanee ^f  

^a QUEEN SIRIKIT NATIONAL INSTITUTE OF CHILD HEALTH   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

^d PRAMONGKUTKLAO HOSPITAL   (Thailand)

^e MAHIDOL UNIVERSITY   (Thailand)

^f Dermatology Institution

Author keywords

Aptopic dermatitis; Pediatric patient; Tacrolimus ointment

Indexed keywords

TACROLIMUS;

APPLICATION SITE BURNING; ARTICLE; ATOPIC DERMATITIS; BURNING SENSATION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSAGE FORM; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ECZEMA; ERYTHEMA; FEMALE; FOLLICULITIS; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OINTMENT; PRURITUS; QUALITY OF LIFE; SCORING SYSTEM; TREATMENT RESPONSE;

ADMINISTRATION, TOPICAL; CHILD; DERMATITIS, ATOPIC; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; OINTMENTS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TACROLIMUS; TREATMENT OUTCOME;

EID: 33845498308     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Bos JD, Smitt JH. Atopic dermatitis. J Eur Acad Dermatol Venerol 1996; 7: 101-14.
2. Hanifin JM. Atopic dermatitis in infants and children. Pediatr Clin North Am 1991; 38: 763-89.
3. Boguniewicz M, Leung DY. New concepts in atopic dermatitis. Compr Ther 1996; 22: 144-51.
4. Rasmussen JE. Management of atopic dermatitis. Allergy 1989; 44(Suppl 9): 108-13.
5. American Academy of Dermatology. Guidelines of care for atopic dermatitis. J Am Acad Dermatol 1992; 26: 485-8.
6. Rasmussen JE. Advances in nondietary management of children with atopic dermatitis. Pediatr Dermatol 1989; 6: 210-5.
7. Hanifin JM. Atopic dermatitis: new therapeutic considerations. J Am Acad Dermatol 1991; 24(6 Pt 2): 1097-101.
8. Brown MA, Hanifin JM. Atopic dermatitis. Curr Opin Immunol 1990; 2: 531-4.
9. de Prost Y. Atopic dermatitis: recent therapeutic advances. Pediatr Dermatol 1992; 9: 386-9.
10. Wahlgren CF, Scheynius A, Hagermark O. Antipruritic effect of oral cyclosporin A in atopic dermatitis. Acta Derm Venereol 1990; 70: 323-9.
11. van Joost T, Heule F, Korstanje M, van den Broek MJ, Stenveld HJ, van Vloten WA. Cyclosporin in atopic dermatitis: a multicentre placebo-controlled study. Br J Dermatol 1994; 130: 634-40.
12. Berth-Jones J, Finlay AY, Zaki I, Tan B, Goodyear H, Lewis-Jones S, et al. Cyclosporine in severe childhood atopic dermatitis: a multicenter study. J Am Acad Dermatol 1996; 34: 1016-21.
13. Korstanje MJ, van de Staak WJ. Cyclosporin maintenance therapy for severe atopic dermatitis. Acta Derm Venereol 1991; 71: 356-7.
14. de Prost Y, Bodemer C, Teillac D. Randomised double-blind placebo-controlled trial of local cyclosporin in atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1989; 144: 136-8.
15. Mrowietz U. The enigma of cyclosporin A treatment for psoriasis: systemic efficacy versus topical non-responsiveness. A review. Acta Derm Venereol 1992; 72: 321-6.
16. Coulson IH, Holden CA. Topical cyclosporin A in alopecia totalis: failure of therapeutic effect due to lack of penetration. Br J Dermatol1989; 121(Suppl 34): 53-4.
17. Gilhar A, Winterstein G, Golan DT. Topical cyclosporine in psoriasis. J Am Acad Dermatol 1988; 18: 378-9.
18. Kino T, Hatanaka H, Hashimoto M, Nishiyama M, Goto T, Okuhara M, et al. FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot (Tokyo) 1987; 40: 1249-55.
19. Kino T, Hatanaka H, Miyata S, Inamura N, Nishiyama M, Yajima T, et al. FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot (Tokyo) 1987; 40: 1256-65.
20. Lauerma AI, Maibach HI. Topical FK506 - clinical potential or laboratory curiosity? Dermatology 1994; 188: 173-6.
21. Kelly PA, Burckart GJ, Venkataramanan R. Tacrolimus: a new immunosuppressive agent. Am J Health Syst Pharm 1995; 52: 1521-35.
22. Nakagawa H, Etoh T, Ishibashi Y, Higaki Y, Kawashima M, Torii H, et al. Tacrolimus ointment for atopic dermatitis. Lancet 1994; 344: 883.
23. Aoyama H, Tabata N, Tanaka M, Uesugi Y, Tagami H. Successful treatment of resistant facial lesions of atopic dermatitis with 0.1% FK506 ointment. Br J Dermatol 1995; 133: 494-6.
24. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1980; 92: 44-7.
25. Rajka G, Langeland T. Grading of the severity of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1989; 144: 13-4.